Latest From Anagenesis Biotechnologies
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in June 2016.
- Gene Therapy, Cell Therapy
- Therapeutic Areas
- Musculoskeletal & Connective Tissue Disorders
- Western Europe
- Parent & Subsidiaries
- Anagenesis Biotechnologies
- Senior Management
- Jean-Yves Bonnefoy, PhD, Pres. & CEO
- Contact Info
Phone: 3 88 43 10 08
650 Boulevard Gonthier d’Andernach
Illkirch Graffenstaden, 67400
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.